should i switch from semaglutide to tirzepatide Switching dosage chart Switching from Tirzepatide to Semaglutide

In Study 7, at Week 64, the body weight was missing for 6.3% and 11.8% of patients randomized to WEGOVY tablets and placebo, respectively

The patient noted becoming symptomatic (chest pain, nausea, cold extremities, dizzy, and seeing spots) and had marked tachycardia (136 beats/min) while seated for a short period during the blood pressure monitoring session

Some tolerate higher doses well and benefit from faster escalation

We are direct about the limits of the evidence

I am 5lbs of my goal and feel great

Weight loss during the first month is often modest - some patients report 2-5 pounds, others report minimal changes